It depends on the case; there is no single guideline.
Hypocalcemia (6.2% in TACT), kidney toxicity, and documented deaths from hypocalcemia with disodium EDTA (not approved by the FDA for heart disease). Contraindicated without confirmed poisoning. No evidence against cancer or as a 'detox'.
Reference treatment when toxic levels are confirmed: CaNa2-EDTA and DMSA (succimer) for lead —DMSA is approved for children—, DMSA/DMPS for mercury and arsenic, deferoxamine for iron. Reduces the body burden of the metal and its effects; it does not replace removing the source of exposure.
View the study (clinical standard) →TACT (JAMA 2013; 1,708 post-heart attack patients): modest reduction in events with disodium EDTA (26% vs 30%, HR 0.82; CI 0.69-0.99; p=0.035) that the authors considered insufficient for routine use. TACT2 (JAMA 2024, diabetic post-heart attack patients) did not confirm it: 35.6% vs 35.7% of events. NIH/NCCIH do not endorse it.
View the study (trials (TACT, TACT2)) →There is no evidence that chelation clears toxins in people without poisoning, or that it has any effect against cancer. Disodium EDTA has caused deaths from hypocalcemia when used as a 'detox'. It only makes sense with confirmed poisoning.
View the study (no trials) →⏱ 2 min read
Chelators (EDTA, DMSA, DMPS, dimercaprol, deferoxamine) trap metal ions and allow them to be excreted in urine. They are the established treatment of confirmed poisoning by lead, mercury, arsenic or of iron overload, always with lab tests that justify it and under medical supervision.
Outside of that, the evidence does not support them. In heart disease after a heart attack, TACT (2013) showed a modest benefit (HR 0.82) that the authors themselves did not consider sufficient for routine use, and TACT2 (2024) did not confirm it. As a general detox or against cancer there is no evidence, and disodium EDTA used that way has caused deaths from hypocalcemia. NIH/NCCIH do not endorse it.
Lamas GA et al. (2013). TACT. JAMA 309(12). PMID 23532240 · TACT2 (2024) JAMA · NCCIH: Questions and Answers, NIH trials of EDTA chelation.
Information, not medical advice. Scientific evidence reflects the quality of the studies.